2-sulfamoylacetylphenol

 

Topic mentions per year

Topic mentions per year

1992-2003
0119922003

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2003
Review
2003
Although the significant progress in pharmacotherapy of epilepsy during last decade was achieved, about one third of patients are… (More)
  • figure 1
Is this relevant?
1996
1996
Zonisamide (1,2-benzisoxazole-3-methanesulfonamide), an anticonvulsant agent, is primarily metabolized to 2-sulfamoylacetylphenol… (More)
Is this relevant?
1993
1993
Zonisamide (1,2-benzisoxazole-3-methanesulfonamide) was metabolized to 2-sulfamoylacetylphenol (SMAP) in human liver microsomes… (More)
Is this relevant?
1993
1993
The reductive metabolism of 1,2-benzisoxazole-3-methanesulfonamide (zonisamide) to 2-sulfamoylacetylphenol (SMAP) was observed in… (More)
Is this relevant?
1992
1992
Zonisamide (1,2-benzisoxazole-3-methanesulfonamide) was metabolized to its reductive product, 2-sulfamoylacetylphenol, in rat… (More)
Is this relevant?